<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01519154</url>
  </required_header>
  <id_info>
    <org_study_id>KEK-ZH Nr. 2011-0190</org_study_id>
    <secondary_id>2011DR3171</secondary_id>
    <nct_id>NCT01519154</nct_id>
  </id_info>
  <brief_title>Sedation MRI - Propofol Versus Propofol-Ketamin in Children</brief_title>
  <official_title>Untersuchung Unterschiedlicher Sedationstechniken f√ºr Elektive Magnetresonanztomographie (MRT)-Diagnostik Bei Kindern Anhand Klinischer Und MRT-basierter Outcomeparameter (Propofol Versus Propofol-Ketamin)</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Achim Schmitz</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University Children's Hospital, Zurich</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Children &lt; 10 years of age often need deep sedation or anaesthesia to allow elective
      diagnostic magnetic resonance imaging; standard routine protocols are

        1. propofol induction without other sedative (Propofol much as needed) or hypnotic drugs
           and propofol infusion 10 mg/kg h

        2. propofol induction with ketamine 1 mg /kg (little repetitive Propofol doses as needed)
           and propofol infusion 5 mg / kg h

      both protocols are compared with regard to clinical outcome and, in cases with cerebral MRI,
      cerebral perfusion/blood flow.

      Hypothesis:

        1. reduces recovery time compared to propofol mono sedation

        2. combination of ketamine-propofol increases incidence of Postoperative nausea and
           vomiting (PONV) compared to propofol mono sedation

        3. combination of ketamine-propofol increases global cerebral blood flow and changes
           regional distribution of cerebral perfusion compared to propofol mono sedation
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>March 2012</start_date>
  <completion_date type="Actual">November 2014</completion_date>
  <primary_completion_date type="Actual">November 2014</primary_completion_date>
  <phase>Phase 3</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <masking>Triple (Participant, Care Provider, Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Recovery time</measure>
    <time_frame>1 - 3 hours post anaesthesia</time_frame>
    <description>Time from end of MRI until recovery defined as Aldrete Score = 10</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Demission time</measure>
    <time_frame>1 - 4 hours post anaesthesia</time_frame>
    <description>time until demission</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>PONV</measure>
    <time_frame>24 hours</time_frame>
    <description>Postoperative nausea or vomiting</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Cerebral perfusion</measure>
    <time_frame>first 10 minutes of MRI</time_frame>
    <description>noninvasive measurement of cerebral perfusion by means of MRI only in patients scheduled for cerebral MRI</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Incidence of emergence delirium</measure>
    <time_frame>1 - 4 hours post anaesthesia</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Quality of sedation</measure>
    <time_frame>during MRI, on the average 45 minutes</time_frame>
    <description>Extra Propofol doses and total amount of Propofol required, movement artefacts</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>respiratory and cardiovascular adverse events</measure>
    <time_frame>during sedation, on the average 60 minutes</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">347</enrollment>
  <condition>Sedation</condition>
  <arm_group>
    <arm_group_label>Propofol</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Propofol 10 mg/h as maintenance infusion</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Ketamine-Propofol</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Additional Ketamine at induction, Propofol 5 mg/h as maintenance infusion</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Propofol</intervention_name>
    <description>Only Propofol titrated for induction, followed by Propofol 10 mg/h as maintenance infusion</description>
    <arm_group_label>Propofol</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Ketamine-Propofol</intervention_name>
    <description>Propofol titrated plus additional Ketamine 1 mg/kg at induction, followed by Propofol 10 mg/h as maintenance infusion</description>
    <arm_group_label>Ketamine-Propofol</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  MRT in deep sedation

          -  outpatient

          -  &gt; 3 months to &lt;= 10 years

        Exclusion Criteria:

          -  tracheal intubation required

          -  contraindication of ketamine or propofol

          -  additional painful procedure requiring analgesics
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>3 Months</minimum_age>
    <maximum_age>10 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Achim J Schmitz, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University Children's Hospital, Zurich</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>University Children's Hospital Zurich</name>
      <address>
        <city>Zurich</city>
        <zip>8032</zip>
        <country>Switzerland</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Switzerland</country>
  </location_countries>
  <verification_date>November 2014</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>January 17, 2012</study_first_submitted>
  <study_first_submitted_qc>January 25, 2012</study_first_submitted_qc>
  <study_first_posted type="Estimate">January 26, 2012</study_first_posted>
  <last_update_submitted>November 26, 2014</last_update_submitted>
  <last_update_submitted_qc>November 26, 2014</last_update_submitted_qc>
  <last_update_posted type="Estimate">December 2, 2014</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor-Investigator</responsible_party_type>
    <investigator_affiliation>University Children's Hospital, Zurich</investigator_affiliation>
    <investigator_full_name>Achim Schmitz</investigator_full_name>
    <investigator_title>Principal Investigator</investigator_title>
  </responsible_party>
  <keyword>deep sedation</keyword>
  <keyword>propofol</keyword>
  <keyword>ketamine</keyword>
  <keyword>child</keyword>
  <keyword>preschool child</keyword>
  <keyword>infant</keyword>
  <keyword>recovery and quality of sedation</keyword>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Propofol</mesh_term>
    <mesh_term>Ketamine</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

